benzylan | Halidor solution for intravenous and intravenous administration 25 mg / ml 2 ml amp 10 pcs

Latin name

Halidor

Release form

Solution for i / o administration



packaging 10 pcs

Indications of

cerebrovascular accident in cerebrovascular diseases of atherosclerotic and angiospastic origin (in combination therapy)

vascular eye diseases (incl. retinal central artery occlusion, diabetic angiopathy)

obliterating diseases of peripheral arteries of various origins, angioedema, postoperative and post-traumatic circulatory disorders

gastric and duodenal ulcer and other gastrointestinal tract, gastrointestinal tract, gastric tract, gastric tract , enteritis, colitis, tenesmus, cholecystopathy, cholelithiasis, postcholecystectomy syndrome)

urinary cramps Tay, adjuvant therapy in urolithiasis.

Contraindications

hypersensitivity to the components of the drug.

renal failure

liver dysfunction

respiratory failure

paroxysmal supraventricular or acute ventricular tachycardia

children and adolescents under 18 years of age (insufficient experience).

severe respiratory failure

severe renal failure

severe liver failure

decompensated heart failure

acute myocardial infarction.

Pregnancy and lactation

Preclinical studies have not shown any embryotoxic or teratogenic effects.

However, sufficient reliable studies on the use of the drug during pregnancy and lactation in humans have not been conducted.

Therefore, the introduction of the drug to patients in the first trimester of pregnancy is not recommended.

During lactation, you should refrain from prescribing the drug, or decide whether to stop breastfeeding during treatment.

Composition

1 amp. contains bencyclan fumarate 50 mg

Dosage and administration

Parenteral administration of the drug is administered intravenously (after dilution) or infusion.

Daily dose of 200 mg divided into 2 injections.

Side effects

Gastrointestinal: dry mouth, abdominal pain, feeling full, decreased appetite, nausea, vomiting, diarrhea.

Central nervous system: anxiety, headache, dizziness, gait disturbance, tremor, sleep disturbance, memory loss, sometimes a transient confused state of consciousness, hallucinations, asthenia, very rarely - symptoms of focal lesions of the central nervous system (CNS), epileptiform seizures.

Cardiovascular system: atrial or ventricular tachyarrhythmia can sometimes occur (especially when co-administered with other proarrhythmogenic drugs).

Laboratory parameters: transient increase in the activity of aspartate aminotransferase and alamine aminotransferase, leukopenia.

Others: general malaise, weight gain, allergic reactions.

Drug Interactions

Caution should be exercised when combined with the following agents:

anesthetics and sedatives - their effects may be enhanced by

drugs for general anesthesia - enhancement of their action by sympathomimetics reducing the level of potassium and quinidine - due to the possible summation of proarrhythmogenic effects

with digitalis drugs - increases the risk of arrhythmia in overdose of digitalis

beta-blockers - because of the opposite of chronotropic effects (negative) dosage of beta blocker

calcium channel blockers and other antihypertensive drugs - because of the possibility of enhancing their effect

drugs mi causing side effects in the form of spasmophilia - due to the possibility of summarizing these effects

acetylsalicylic acid - due to increased inhibition of platelet aggregation.

Overdose

Symptoms: increased heart rate, decreased blood pressure, collapse, incontinence, drowsiness, anxiety, and in severe cases, epileptiform seizures. A significant overdose can cause tonic-clonic seizures.

Treatment: No specific antidote is known. In case of overdosage, the stomach should be washed and symptomatic treatment prescribed. There are no data on the possible excretion of benzyclane by dialysis.

Storage conditions

The drug should be stored out of the reach of children at a temperature of 15 ° to 25 РC.

Expiration

5 years.

Deystvuyuschee substances

Bentsyklan

pharmacy terms

prescription

Dosage form

Dosage form

solution for injection and infusion